Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

California’s Indoor Heat Protections Go into Effect

When temperatures reach 87°F, employers must implement work-rest schedules and provide personal heat protective equipment, where feasible.
Read More →
July 29, 2024

WCRI Publishes Behavioral Health Report for New York State

About 3% of claims had services for behavioral health, representing 8% of total medical payments
Read More →
August 5, 2024

California WCRIB Releases State of the System Report

Pharmaceutical costs decreased 88% since 2012, but medical costs are increasing due to longer claim durations and inflationary updates to fee schedules.
Read More →
August 5, 2024

California Supreme Court Rules Rideshare Drivers are Contractors

Proposition 22's exemption for rideshare drivers was upheld after four years of litigation.
Read More →
August 5, 2024

WCRI Webinar on Interstate Variation in Drug Trends

Healthe attended the August 1st webinar to capture key findings.
Read More →
August 12, 2024

Massachusetts Considers Psychedelics Initiatives

A Voter Initiative may allow for therapeutic use, while a new bill could allow for a working group would explore treatment for veterans.
Read More →
August 12, 2024

WCRI Reports on Factors Associated with High-Cost Claims

High-cost claims are defined as the top 5% of medical payments within 36 months of injury.
Read More →
August 19, 2024

West Virginia Issues Bulletin on AI

Regulators endorsed the Principles of Artificial Intelligence adopted by the NAIC as a framework for insurers.
Read More →
August 19, 2024

Texas Invites Stakeholder Comments on Agenda, Rules, Quarterly Meetings

Stakeholders can submit written comments through September 16th.
Read More →
August 19, 2024
1 … 36 37 38 39

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

FDA Approves Two Migraine Drugs and Two NSAIDs

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.
Read More

2020 Workers’ Comp Industry Insights Survey

Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.
Read More

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Read More

Embracing Telehealth in Reaction to COVID-19

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.
Read More

Sandy Shtab Featured in IAIABC Member Spotlight

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.
Read More

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.
Read More
1 … 36 37 38 39 40 … 47
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle